In-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.
About
ShanX Medtech is a medtech company developing in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing. Their technology enables clinicians to identify the most effective antibiotic directly from patient samples in approximately one hour, significantly faster than traditional methods. This supports faster, evidence-based treatment decisions and aims to combat antimicrobial resistance.
Tags
Total Employees
16
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ShanX Medtech do?
ShanX Medtech is a medtech company developing in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing. Their technology enables clinicians to identify the most effective antibiotic directly from patient samples in approximately one hour, significantly faster than traditional methods. This supports faster, evidence-based treatment decisions and aims to combat antimicrobial resistance.
How much funding has ShanX Medtech raised?
ShanX Medtech has raised a total of $28M in funding. The most recent round on record is Grant.
When was ShanX Medtech founded?
ShanX Medtech was founded in 2019.
What industry does ShanX Medtech operate in?
ShanX Medtech operates in HealthTech, Biotechnology, Diagnostics, MedTech, In-Vitro Diagnostics, Antimicrobial Resistance.
How many employees does ShanX Medtech have?
ShanX Medtech has approximately 16 people on record.